📰 Spherix Network News
Page 5 - Spherix Network News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Spherix Network. Real-time updates on events, politics, business and more.
January 20, 2023
/PRNewswire/ -- With the approvals of GlaxoSmithKlines Benlysta (belimumab) in lupus nephritis (LN) at the end of 2020 and Aurinias Lupkynis (voclosporin) at...
January 18, 2023
/PRNewswire/ -- The switch landscape represents an active segment of the market where brands have the opportunity to capture share. Spherixs RealWorld...
January 10, 2023
/PRNewswire/ -- Ophthalmologists saw the entry of the first biosimilars into the armamentarium in 2022 with the launch of Biogen and Samsungs Byooviz and...
January 10, 2023
/PRNewswire/ -- Ophthalmologists saw the entry of the first biosimilars into the armamentarium in 2022 with the launch of Biogen and Samsungs Byooviz and...
December 21, 2022
/PRNewswire/ -- Spherix Global Insights, a leading provider of market research, business intelligence, and advisory services to the global life sciences...
December 9, 2022
/PRNewswire/ -- On September 9, 2022, BMS announced the FDA approval of Sotyktu for moderate-to-severe plaque psoriasis (PsO), making it the first selective...
December 7, 2022
/PRNewswire/ -- On October 28, 2022, the European Medicines Agencys (EMA) safety committee (PRAC) announced recommendations to minimize the risk of serious...
December 6, 2022
/PRNewswire/ -- After a regulatory debacle in the United States which ended with FibroGen and AstraZeneca receiving a Complete Response Letter in August 2021...
December 6, 2022
/PRNewswire/ -- After a regulatory debacle in the United States which ended with FibroGen and AstraZeneca receiving a Complete Response Letter in August 2021...
November 30, 2022
/PRNewswire/ -- US gastroenterologists estimate that just under 60% of their ulcerative colitis (UC) and 55% of their Crohns disease (CD) patients treated...